American Healthcare REIT ... (AHR)
NYSE: AHR
· Real-Time Price · USD
40.41
0.02 (0.05%)
At close: Aug 15, 2025, 3:44 PM
American Healthcare REIT Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Revenue | 542.5M | 540.6M | 542.74M | 523.81M | 504.58M | 499.53M | 482.55M | 463.18M | 461.19M | 452.23M | 449.62M | 419.63M | 377.33M | 370.92M | 359.64M |
Cost of Revenue | 12.99M | 432.42M | 430.57M | 417.13M | 402.56M | 403.63M | 385.01M | 374.6M | 372.55M | 370.15M | 360.82M | 337.49M | 296.06M | 287.16M | 284.54M |
Gross Profit | 529.51M | 108.18M | 112.17M | 106.69M | 102.02M | 95.9M | 97.54M | 88.57M | 88.64M | 82.08M | 88.8M | 82.14M | 81.27M | 83.76M | 75.11M |
Operating Income | 116.22M | 40.27M | 40.15M | 37.37M | 31.68M | 27.58M | 29.21M | 14.45M | 23.89M | 9.16M | 19.88M | 23.78M | 26.68M | 20.25M | 55.52M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 10.81M | -6.24M | -31.94M | -2.83M | 3.61M | -2.73M | -31.07M | -6.16M | -11.52M | -27.47M | -49.21M | -7.52M | -15.34M | -729K | -24.83M |
Net Income | 9.91M | -6.8M | -31.77M | -4.13M | 1.98M | -3.89M | -27.43M | -5.99M | -12.18M | -25.87M | -47.53M | -13.51M | -17.31M | -2.96M | -23.03M |
Selling & General & Admin | 14.94M | 26.8M | 25.1M | 25.07M | 25.07M | 25.55M | 24.39M | 25.92M | 26.43M | 28.25M | 26.63M | 24.48M | 25.59M | 26.41M | 19.59M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 398.35M | 41.11M | 46.91M | 44.25M | 45.26M | 42.77M | 43.93M | 48.21M | 38.32M | 44.67M | 42.29M | 33.89M | 29M | 37.1M | n/a |
Operating Expenses | 413.3M | 67.91M | 72.02M | 69.32M | 70.33M | 68.32M | 68.32M | 74.13M | 64.75M | 72.92M | 68.92M | 58.37M | 54.59M | 63.5M | 19.59M |
Interest Expense | -22.63M | 22.95M | 30.3M | 30.39M | 30.6M | 36.44M | 41.19M | 42.01M | 40.99M | 39.01M | 34.76M | 27.52M | 20.34M | 23.32M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 426.29M | 500.33M | 502.59M | 486.44M | 472.9M | 471.95M | 453.34M | 448.73M | 437.3M | 443.06M | 429.74M | 395.85M | 350.65M | 350.66M | 304.13M |
Income Tax Expense | 732K | 604K | 486K | 263K | 686K | 278K | -112K | 284K | 348K | 143K | 87K | 126K | 205K | 168K | 171K |
Shares Outstanding (Basic) | 160.5M | 156.92M | 153.7M | 133.73M | 130.53M | 104.3M | 66.05M | 66.05M | 66.03M | 66.03M | 66.15M | 66.08M | 66.08M | 66.21M | 65.6M |
Shares Outstanding (Diluted) | 161.14M | 156.92M | 153.7M | 133.73M | 130.69M | 104.3M | 66.05M | 66.05M | 66.03M | 66.03M | 66.15M | 66.08M | 66.08M | 66.21M | 65.6M |
EPS (Basic) | 0.06 | -0.04 | -0.21 | -0.03 | 0.02 | -0.04 | -0.42 | -0.09 | -0.18 | -0.39 | -0.72 | -0.2 | -0.26 | -0.04 | -0.35 |
EPS (Diluted) | 0.06 | -0.04 | -0.21 | -0.03 | 0.02 | -0.04 | -0.42 | -0.09 | -0.18 | -0.39 | -0.72 | -0.2 | -0.26 | -0.04 | -0.35 |
EBITDA | 87.66M | 67.64M | 55.42M | 81.47M | 90.32M | 88.28M | 62.19M | 99.05M | 86.45M | 76.58M | 42.12M | 69.57M | 51M | 71.07M | 63.65M |
EBIT | 45.72M | 16.71M | -1.64M | 27.57M | 34.21M | 33.71M | 10.11M | 35.84M | 29.47M | 11.54M | -14.45M | 20.01M | 5.01M | 22.6M | 739K |
Depreciation & Amortization | 41.94M | 50.93M | 57.06M | 53.9M | 56.11M | 54.57M | 52.08M | 63.2M | 56.98M | 65.04M | 56.57M | 49.56M | 45.99M | 48.48M | 62.91M |